Checkpoint kinase 1 (CHK1) inhibitors and uses thereof
US11707462B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2022 |
| Grant date | Jul 25, 2023 |
| Priority date | — |
| Expiry date | Aug 29, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds and methods for the treatment of cancer. The methods include administering to a subject in need a therapeutically effective amount of a Chk1 inhibitor disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.